A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantationNurdan Taçyıldız, Gülsan Yavuz, Emel Ünal et al.|The Turkish Journal of Pediatrics|2019Cited by 5